MedPath

Constraint-induced Movement Therapy for Perinatal Brachial Plexus Injury

Not Applicable
Completed
Conditions
Neonatal Brachial Plexus Palsy
Registration Number
NCT03765034
Lead Sponsor
Children's Hospital Los Angeles
Brief Summary

This study evaluates the addition of constraint-induced movement therapy (CIMT) to usual care occupational therapy in children with perinatal brachial plexus injury. Participants are randomized to receive either the intervention (CIMT) or control first, then cross over to receive the other one.

Detailed Description

Children with perinatal brachial plexus injury routinely receive occupational therapy intervention to improve strength and function in their weak or paralyzed arm.

Constraint-induced movement therapy (CIMT) is known to increase upper extremity function in children with weakness or disuse as a result of cerebral palsy. However, it is unknown if this therapy is effective for treating arm weakness or disuse as a result of perinatal brachial plexus injury. The addition of CIMT to usual and standard occupational therapy care is evaluated in this trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Participant has perinatal brachial plexus injury
  • Participant walking at time of study inception
  • Ability to cooperate with interventions and assessment
  • Participant currently receiving occupational therapy 1+ hour per week and planning to continue for duration of study
Exclusion Criteria
  • Co-morbid diagnosis not related to perinatal brachial plexus injury
  • Flaccidity of the involved upper extremity or no observable hand function
  • Planned surgery or drug intervention during the study period
  • Allergy or intolerance to constraint intervention materials

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Assisting Hand Assessment 5.0change from baseline at 8 weeks and 16 weeks

Criterion-referenced observational scale of affected hand use during bimanual performance. Each item is score 1-4 (1 = does not do; 2 = ineffective; 3 = somewhat effective; 4 = effective), yielding a Rasch-modeled standardized score between 0 and 100.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.